
Ryan Henrici, a class of 2015 graduate who majored in biochemistry and molecular biology, is one of eight prominent young alumni who will be honored by the Penn State Alumni Association at the 2025 Alumni Achievement Awards Ceremony on Friday, March 28, at 6 p.m. The event will be livestreamed.
The award is one of the Alumni Association’s most prestigious honors. Recipients are nominated by an academic college or campus and invited by the president of the University to return to Penn State to share their expertise with students and the University community. They demonstrate to students that Penn State alumni can succeed in exceptional fashion at an early age.
“It’s an honor to recognize these deserving Penn Staters,” said Ryan Jones, interim executive officer of the Penn State Alumni Association. “Each award recipient is making a unique difference in their field, and their successes highlight the impact Penn Staters can have on a national and global scale.”
Henrici is senior director of translational research at BigHat Biosciences, where he leads development of next-generation antibody therapeutics. During the COVID-19 pandemic, he led efforts to develop therapeutic antibodies for treating and preventing SARS-CoV-2 infection.
A Marshall Scholar, Astronaut Scholar and Barry M. Goldwater Scholar, Henrici also received the Eric A. Walker Award, given to students whose work enhances Penn State’s public esteem and renown. His career achievements include the American Society of Hematology's Early Career Achievement Award and the EMBL Best Short Talk Prize. At Penn State, he served on the President's Council on Engaged Scholarship and was a Schreyer Scholar.
Visit the Alumni Association website for more information on the honorees and the Alumni Achievement Award.